INOVIO PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Accumulated Amortization
INOVIO PHARMACEUTICALS, INC. (INO) had Finite-Lived Intangible Assets, Accumulated Amortization of $7.17 million as of 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2024-03-06
- 2023-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $7.17M.
- 2023-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $7.17M.
- 2023-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $7.17M.
- 2023-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $7.10M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2023-12-31 | $7.17M 10-K · filed 2024-03-06 | |
| 2023-09-30 | $7.17M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.17M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.10M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $8.34M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $8.22M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $8.10M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $7.97M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $7.85M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $7.72M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $7.59M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $7.46M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $7.33M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $7.19M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $7.05M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.92M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.78M 10-K · filed 2021-03-01 | $21.02M 10-K · filed 2020-03-12 |
| 2019-09-30 | $20.76M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.49M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $20.22M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $19.96M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $19.69M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $19.42M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $19.11M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $18.71M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $18.30M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $17.90M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $17.50M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $17.09M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $16.68M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $16.27M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $15.92M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $15.71M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $15.50M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $15.28M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $15.07M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $14.84M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $14.61M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $14.38M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $14.14M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $13.90M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $13.46M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $13.02M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $12.58M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $12.13M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $11.68M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $11.22M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $10.31M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |